You have been inactive for 0 mins.
Stay logged in or you will be logged off in 60 seconds.
This fund was launched in 2018 to replicate a successful strategy employed by T.Rowe Price in the US. The manager, Taymour Tamaddon, has been part of the team since January 2017 and has a solid background in the US market as a healthcare sector specialist. He has carefully implemented this well-established process that draws on in-house research, taking advantage of the research analysts' top ideas. The fund is concentrated, with around 60 holdings. Tamaddon takes big positions in market leaders, such as Amazon, but will also include less well-known names that meet his exacting criteria. He has a bias to companies with double-digit earnings potential over 3 years but some defensive exposure is added to limit risk during market setbacks.
Below is the online factsheet for your selected instrument. You can change time periods in certain areas of the factsheet and generate a version to PDF using the "Print" button.
You can also view an Analyst Report as a PDF using the link below and if you are a registered user a more detailed report is also available.Analyst Report